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he low-density lipoprotein receptor–related protein
(Lrp)-5 functions as a Wnt coreceptor. Here we show
that mice with a targeted disruption of 
 
Lrp5
 
 develop a
low bone mass phenotype. In vivo and in vitro analyses
indicate that this phenotype becomes evident postnatally,
and demonstrate that it is secondary to decreased osteoblast
proliferation and function in a 
 
Cbfa1
 
-independent manner.
 
Lrp5
 
 is expressed in osteoblasts and is required for optimal
T
 
Wnt signaling in osteoblasts. In addition, Lrp5-deﬁcient
mice display persistent embryonic eye vascularization due to
a failure of macrophage-induced endothelial cell apoptosis.
These results implicate Wnt proteins in the postnatal
control of vascular regression and bone formation, two
functions affected in many diseases. Moreover, these features
recapitulate human osteoporosis-pseudoglioma syndrome,
caused by 
 
LRP5
 
 inactivation.
 
Introduction
 
The low-density lipoprotein receptor (LDLR)* gene family
encodes cell surface receptors conserved from 
 
Caenorhabditis
elegans
 
 to humans (Hussian et al., 1999; Willnow, 1999;
Herz and Beffert, 2000) that are characterized by the presence
of cysteine-rich complement-type LDLR ligand-binding
domains (Herz and Beffert, 2000). There are at least ten
members of the LDLR gene family in mammals, and five
of these (LDLR, very low-density lipoprotein receptor,
apolipoprotein E receptor-2, LDLR-related protein [LRP]-1,
and megalin) recognize apolipoprotein E as one of their
ligands. Five other LRPs have been described: LRP3 (Ishii et
al., 1998); LRP4 (Tomita et al., 1998); LR11 (Yamazaki et
al., 1996); LRP5 (Dong et al., 1998; Hey et al., 1998; Kim
et al., 1998); and LRP6 (Brown et al., 1998). Although the
ligands for most of these receptors are unknown, recent
studies in 
 
Drosophila
 
 have identified a class of ligands for
Lrp5 and Lrp6, and thereby a signaling pathway in which
they act.
In 
 
Drosophila
 
, arrow encodes a single-pass transmembrane
protein thought to act as a coreceptor for wingless, as inacti-
vation of arrow results in a wingless-like phenotype (Wehrli,
1999). Arrow is an LRP strikingly homologous to vertebrate
LRP5 and LRP6 (Wehrli, 1999; Pinson et al., 2000; Tamai
et al., 2000). This sequence homology is consistent with the
multiple Wnt deficiency–like phenotypes of Lrp6-deficient
mice (Pinson et al., 2000). Lrp5, the other homologue of ar-
row and a close relative of Lrp6, is involved in Wnt signaling
in vitro. Indeed, in NIH3T3 fibroblasts, the interaction of
Lrp5 with Axin is initiated by Wnt treatment of these cells
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(Mao et al., 2001). The observation that overexpression of
 
Lrp6
 
,
 
 
 
but not of 
 
Lrp5
 
, induced dorsal axis duplication in 
 
Xe-
nopus
 
 (Tamai et al., 2000) indicates that these two receptors
control different functions, presumably by interacting with
distinct ligands of the Wnt family.
The Wnt proteins are secreted proteins that control multi-
ple developmental processes including mesoderm induction,
cell fate determination, limb patterning, and organogenesis
(Parr and McMahon, 1998; Wodarz and Nusse, 1998;
Vainio et al., 1999; Hartmann and Tabin, 2001). Wingless
in 
 
Drosophila
 
 and Wnt proteins in vertebrates initiate these
events by binding to seven transmembrane domain receptors
of the Frizzled family (Bhanot et al., 1996; Wodarz and
Nusse, 1998). Wnt binding to Frizzled results in stabiliza-
tion of 
 
 
 
-catenin, which then interacts with transcription
factors of the Lef/Tcf family to activate specific gene expres-
sion programs (Huelsken and Birchmeier, 2001). Distinct
Wnt proteins control early events during skeletal develop-
ment such as limb patterning (Perrimon and McMahon,
1998) and joint formation (Hartmann and Tabin, 2001).
However, the recent findings that 
 
LRP5
 
 is inactivated in os-
teoporosis-pseudoglioma syndrome patients (Gong et al.,
2001) and is mutated in patients with the high bone mass
syndrome (Little et al., 2002) strongly suggest that Wnt pro-
teins may control other aspects of skeletal biology later dur-
ing development and postnatally.
Through the analysis of mice lacking most of the Lrp5
protein we present evidence that the Lrp5 signaling pathway
is required for osteoblast proliferation as well as for bone
matrix deposition by differentiated osteoblasts. Surprisingly,
these phenotypic abnormalities occur in the context of nor-
mal 
 
Cbfa1/Runx2
 
 (
 
Cbfa1
 
) expression, a gene usually viewed
as controlling osteogenesis (Karsenty, 1999). Thus, these re-
sults suggest a role for Cbfa1-independent pathways in the
control of osteoblast proliferation and function. Biochemical
and expression evidence indicates that Lrp5 binds directly to
Wnt proteins and is required for optimal signaling of a dis-
tinct subset of Wnt proteins belonging to the Wnt1 subfam-
ily in osteoblasts. Lrp5 is also necessary for the normal re-
gression of embryonic vasculature in the eye. Together, these
results demonstrate that the Lrp5 signal transduction path-
way, and thereby Wnt proteins, regulate osteoblast prolifera-
tion, function, and eye vascularization during late develop-
ment and after birth.
 
Results
 
Generation of 
 
Lrp5
 
 
 
/
 
 
 
 mice
 
Lrp5
 
 encodes a 1,614-amino acid transmembrane protein
with an extracellular domain containing EGF-like and
LDLR domains, a small transmembrane domain, and an in-
tracellular domain (Fig. 1 A). 
 
Lrp5
 
 is very broadly expressed
(Fig. 1 B). To inactivate 
 
Lrp5
 
 in mice, we generated an allele
that disrupts the extracellular domain, resulting in a trun-
cated polypeptide due to the insertion of an IRES-
 
LacZ-
Neomycin
 
 cassette at amino acid 373 (Fig. S1, A and B). A
very similar mutation is found in human patients and results
in the same phenotypic consequences as those observed with
a complete deletion of the gene (Gong et al., 2001).
Chimeras generated from two independent targeted
clones transmitted the mutation through the germ line, and
the phenotypic abnormalities described below were observed
in mutant mice derived from both of these targeted clones.
Northern blot analysis of liver RNA failed to detect 
 
Lrp5
 
 ex-
Figure 1. Targeted disruption of Lrp5. (A) Structure of 
the Lrp5 protein and location of targeted disruption of 
Lrp5 (vertical arrow). (B) Northern blot analysis showing a 
broad pattern of Lrp5 expression. Gapdh was used as a 
control for RNA integrity. (C) Northern blot analysis 
showing no Lrp5 transcript in Lrp5
2/2 animals using a 39 
probe (left) and the presence of a truncated transcript 
when using a 59 probe (right). 
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pression in 
 
Lrp5
 
 
 
/
 
 
 
 
 
mice (Fig. S1 C, left) when using a
probe derived from exons 10 to 12, indicating that the dis-
rupted exon 6 is not being skipped by the splicing machin-
ery to recreate a near normal transcript. Using a 5
 
 
 
 probe de-
rived from exons 1 and 2 we could detect a truncated
transcript in 
 
Lrp5
 
 
 
/
 
 
 
 
 
mice (Fig. S1 C, right). Immunohis-
tochemistry demonstrated the presence of the truncated
polypeptide in osteoblasts (Fig. 2).
Heterozygous (
 
Lrp5
 
 
 
/
 
 
 
) mice appeared phenotypically
normal. Crosses between heterozygotes produced litters of
normal size, and Southern blot analysis revealed that 
 
Lrp5
 
 
 
/
 
 
 
mice were recovered at close to the expected Mendelian ratio
(Fig. S1 C). 
 
Lrp5
 
 
 
/
 
 
 
 
 
mice had a normal morphological ap-
pearance and were viable and fertile, although a small but
significant number of them died within the first month of
life, presumably after fractures (see below). The penetrance
and the severity of the two phenotypes described below were
identical on a C57BL/6Jx129/SvEv or a 129/SvEv genetic
background.
 
Immunolocalization of Lrp5
 
To identify the cell types producing Lrp5, we used an anti-
body directed against the amino terminal part of the mole-
cule which is still transcribed in 
 
Lrp5
 
 
 
/
 
 
 
 
 
mice (Figueroa et
al., 2000). By immunohistochemistry we observed the pres-
ence of the protein in osteoblasts lining the endosteal and
trabecular bone surfaces (Fig. 2, A–G). We could not detect
any expression in osteoclasts (unpublished data). Lrp5 pro-
tein was detected only in F4/80-positive macrophages found
closely associated with the vitreous microvasculature of the
eye (Fig. 2, H–M). Consistent with its broad pattern of
RNA expression, Lrp5 was also detected in other tissues in-
cluding liver, pancreas, skin, and brain (Figueroa et al.,
2000; unpublished data).
 
Low bone mass phenotype in 
 
Lrp5
 
 
 
/
 
 
 
 mice
 
A small number of mutant animals were limping while walk-
ing, suggesting the existence of a skeleton-related abnormal-
ity. Radiographic analysis of one of these mutant mice at 2
mo of age revealed the presence of a fracture in the tibia be-
traying the existence of a low bone mass phenotype (Fig. S2)
that was present in all 
 
Lrp5
 
 
 
/
 
 
 
 
 
mice at that age (Fig. 3 A; un-
published data).
Histological analysis of the skeleton of 2-mo-old 
 
Lrp5
 
 
 
/
 
 
 
mice revealed a significant decrease in bone volume com-
pared to wild-type littermates, and this low bone mass phe-
notype was observed in all mutant animals analyzed regard-
less of sex and at all stages analyzed (Fig. 3 B; unpublished
data). In particular, analysis of mice at 2 wk of age revealed a
marked decrease in the quantity of mineralized bone in the
primary spongiosa of 
 
Lrp5
 
 
 
/
 
 
 
 mice (Fig. 3 C). As a result,
mutant mice fail to acquire as much bone as wild-type litter-
mates early during life, and their bone mass remains lower
throughout life (Fig. 3 D). Serum and urine levels of cal-
Figure 2. Lrp5 expression in osteoblasts and ocular macrophages. (A–C) Lrp5 expression in osteoblasts and bone lining cells in the primary 
spongiosa of the femur in wild-type mice. (A) Hoechst nuclear staining is shown in blue; (B) Anti-Lrp5 immunoreactivity in red. (C) A merge 
of the red and blue channels. (D) DIC image of distal femur from wild-type with a box showing the region examined in A–C. (E–G) Lrp5 
expression in the primary spongiosa of the femur in Lrp5
 /  mice. (E) Hoechst nuclear staining. (F) Anti-Lrp5 immunoreactivity. (G) Merge. 
(H–M) Whole-mount preparations of hyaloid vessels from wild-type (H–J) and Lrp5
 /  (K–M) mice. (H and K) Immunoreactivity for Lrp5. 
(I and L) Immunoreactivity with the macrophage-specific antibody F4/80, both with Hoechst nuclear staining. (J and M) Merge of the red, 
blue, and green channels; yellow cells indicate that macrophages are positive for Lrp5. 
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cium and phosphate were normal in 
 
Lrp5
 
 
 
/
 
 
 
 
 
mice, indicat-
ing that the low bone mass phenotype was not due to a met-
abolic perturbation (Table 1).
Osteoporosis-pseudoglioma, a rare syndrome caused by
inactivating mutations in 
 
LRP5
 
 in humans (Gong et al.,
2001), is usually viewed as an autosomal recessive disease
(Gong et al., 1996). However, because two obligate het-
erozygote individuals had severe osteoporosis (Superti-Furga
et al., 1986), we studied the bones of 
 
Lrp5
 
 
 
/
 
 
 
 
 
mice. As
shown in Fig. 3 D, 6-mo-old 
 
Lrp5
 
   
 
 mice had a signifi-
cantly lower bone volume than their wild-type littermates,
indicating that this is a dominant phenotype. That the low
bone mass phenotype was noticeably more severe in 
 
Lrp5
 
 
 
/
 
 
 
mice than in 
 
Lrp5
 
 
 
/
 
 
 
 mice reinforces the notion that the en-
gineered mutation is a loss-of-function mutation.
 
Decreased bone formation postnatally in 
 
Lrp5
 
 
 
/
 
 
 
 mice
 
The cellular basis of this low bone mass phenotype was stud-
ied using histomorphometric analyses and biochemical and
cell-based assays. The bone formation aspect of bone remod-
eling was analyzed by measuring the bone formation rate
(BFR), an indicator of osteoblast activity, after in vivo dou-
ble labeling with calcein, a marker of newly formed bone. In
6-mo-old 
 
Lrp5
 
 
 
/
 
 
 
 mice there was a twofold decrease in the
BFR compared with wild-type littermates (Fig. 4 A). A simi-
lar difference was observed in 2- and 4-mo-old 
 
Lrp5
 
 
 
/
 
 
 
 mice
(unpublished data). The decreased BFR was solely due to a
decreased matrix apposition rate (MAR) (Fig. 4 A, arrow),
an index of the amount of bone matrix deposited per osteo-
blast cluster (0.75 
 
  
 
0.05 vs. 0.45 
 
  
 
0.06 
 
 
 
m/d; 
 
P 
 
  
 
0.05)
(Aaron et al., 1984). This decreased MAR directly demon-
strates a functional defect of osteoblasts in vivo in the ab-
sence of Lrp5. Consistent with the dominant nature of the
osteoporosis-like phenotype, the BFR was also significantly
decreased in 
 
Lrp5
 
 
 
/
 
 
 
 mice (88.6 
 
  4.8 vs. 60.5   3.9  m
3/
 m
2/y; P   0.05). We also performed osteoblast counts in
the primary and secondary spongiosa. The results obtained
were identical in both cases: total osteoblast number per
bone area was significantly decreased in Lrp5
 /  mice (Fig. 4
B). To further study osteoblast function, we assayed the abil-
ity of primary osteoblast cultures to mineralize an extracellu-
lar matrix (ECM). As shown in Fig. 4 C, mineralization of
the ECM surrounding Lrp5
 /  osteoblasts was delayed com-
pared with what we observed in wild-type osteoblasts at day
10 of culture. This latter finding supports the notion that
Lrp5
 /  osteoblasts have a functional defect. However, it
may alternatively be explained by the abnormal proliferation
of  Lrp5
 /  osteoblasts (see below). The growth plate of
Lrp5
 /  mice appeared normal, indicating that chondrogen-
esis was not overtly affected (Fig. 4 D).
To define the earliest time point when the bone pheno-
type of the Lrp5
 /  mice could be detected we stained skele-
tal preparations of 17.5 d postcoitum (dpc) embryos, new-
born, and 4-d-old (P4) wild-type and Lrp5
 /  mice with
Alizarin red/Alcian blue. Alcian blue stains proteoglycan-
rich cartilage ECM, whereas Alizarin red stains mineralized
Figure 3. Low bone mass in Lrp5
 /  
mice. (A) Radiograph of the whole body 
of 2 mo-old wild-type and Lrp5
 /  mice 
showing decreased lucency of the entire 
Lrp5
 /  skeleton. (B) Histological analysis 
of vertebrae from 2-mo-old wild-type 
and Lrp5
 /  mice showing low bone 
mass in the mutant mice. (C) Histological 
analysis of vertebrae from 2-wk-old 
wild-type and Lrp5
 /  mice showing a 
decreased number of trabeculae in the 
primary spongiosa of Lrp5
 /  mice. 
(D) Lrp5
 /  mice have a lower bone 
mass throughout life. Green triangle 
indicates a significantly lower bone 
mass in Lrp5
    mice. Asterisks indicate 
a statistically significant difference 
between two groups of mice (P   0.05). 
Error bars represent SD.
Table I. Serum and urine calcium and phosphate concentrations
Analyte Genotype Mean SD
Serum calcium (mg/dl)     9.58 0.41
    9.53 1.15
Serum phosphate (mg/dl)     6.84 0.47
    7.38 1.75
Urine calcium:creatinine     1.09 0.94
    1.04 0.18
Urine phosphate:creatinine     45.9 11.4
    33.1 25.7Wnt regulation of bone formation | Kato et al. 307
Figure 4. Functional defect in Lrp5
 /  
osteoblasts. (A) Calcein double labeling 
in 6-mo-old wild-type and Lrp5
 /  mice. 
The distance between the two labels 
(double-headed arrows) represents the 
MAR which is decreased in Lrp5
 /  
mice. As a result, the BFR is significantly 
lower in Lrp5
 /  mice. (B) Decreased 
osteoblast number per bone area in the 
primary (left) and secondary (right) 
spongiosa of Lrp5
 /  mice compared 
with wild-type. (C) Delayed mineralization 
in primary Lrp5
 /  osteoblast cultures 
compared with wild-type cultures at day 
10 of mineralization. (D) Normal tibial 
growth plate in 2-mo-old Lrp5
 /  mice 
(von Kossa stain). Asterisks indicate a 
statistically significant difference be-
tween two groups of mice (P   0.05). 
Error bars represent SD.
Figure 5. Postnatal onset of the bone 
phenotype in Lrp5
 /  mice. (A) Subtle 
delay of fifth middle phalanx ossification 
in newborn Lrp5
 /  mice. (B) Delayed 
ossification of metacarpals. (C) Carpals 
(bracket). (D) Humeri in 4-d-old Lrp5
 /  
mice. Arrows in A, B, and D indicate 
ossification centers. A subtle delay was 
also evident in 44% (8/18) of heterozygote 
mice (D, middle). (E) Sections of calvaria 
from 4-d-old mice showing a decreased 
number of BrdU-positive cells (arrow-
head) in Lrp5
 /  mice compared with 
wild-type littermates. Double-headed 
arrows indicate the greater thickness of 
wild-type calvarium. (F) Osteoblast 
mitotic index (percentage of BrdU-positive 
cells per total cell number) in wild-type 
and Lrp5
 /  mice (n   8 per genotype). 
(G) Quantification of alkaline phosphatase 
positive stromal cell progenitors (CFU-F) 
in the bone marrow of wild-type and 
Lrp5
 /  mice (n   9 mice per genotype). 
(H) Quantification of apoptotic cells by 
TUNEL assay in wild-type and Lrp5
 /  
mice (n   5 per genotype). (I) Northern 
blot analysis of Cbfa1 expression in 
wild-type and Lrp5
 /  calvaria, long 
bones and primary osteoblasts. (J) 
Northern blot analysis of Osteocalcin 
expression in wild-type and Lrp5
 /  
calvaria and long bones. (I and J) Gapdh 
expression level was used as a loading 
control; results are representative of 
three samples (n   3 mice per sample). 
Asterisks indicate a statistically significant 
difference between two groups of mice 
(P   0.05). Error bars represent SD.308 The Journal of Cell Biology | Volume 157, Number 2, 2002
ECM. There was no ossification defect in any skeletal ele-
ment in 17.5 dpc Lrp5
 /  embryos (unpublished data). In
contrast, in newborn Lrp5
 /  mice, a subtle delay in osteo-
genesis could be observed in the digits as shown by the ab-
sence of the fifth middle phalangeal ossification center (Fig.
5 A, arrow). In 4-d-old mutant mice, the delay in osteogene-
sis became more pronounced and ossification centers of the
wrist, distal metacarpal bones, femora, humeri, and ulnae
that stained red in wild-type mice were absent or smaller in
Lrp5
 /  mice (Fig. 5, B–D, and unpublished data). Consis-
tent with their osteopenic phenotype, we observed a milder
delay of osteogenesis in Lrp5
    mice (Fig. 5 D). Collec-
tively, these data demonstrate that skeletal development ap-
pears to proceed normally until 17.5 dpc, after which osteo-
genesis and bone formation become hampered.
The bone resorption aspect of bone remodeling was first
analyzed by measuring urinary elimination of deoxypyridino-
line crosslinks (Dpd), a biochemical marker of bone resorp-
tion, and the number of osteoclasts. Both parameters were
identical in wild-type and mutant mice (urine Dpd/creatinine
ratio 10.3   2.1 in wild-type mice vs. 11.0   6.2 in Lrp5
 / 
mice). We also assayed for the ability of spleen and bone mar-
row precursor cells to differentiate into tartrate-resistant acid
phosphatase (TRAP)-positive osteoclasts in vitro, as well as
their ability to resorb bone in vitro, and we did not observe
any difference between wild-type and Lrp5
 /  cells (unpub-
lished data). Taken together, these data indicate that bone re-
sorption is not overtly affected in Lrp5
 /  mice.
Abnormal osteoblast proliferation and normal Cbfa1 
expression in Lrp5
 /  mice
The perinatal onset of the osteogenesis defect, along with
the decreased number of osteoblasts in Lrp5
 /  mice, sug-
gested that Lrp5 could be required for osteoblast prolifera-
tion and/or differentiation. To determine if osteoblast pro-
liferation was affected, we measured the number of cells
actively synthesizing DNA by 5-bromo-2 -deoxy-uridine
(BrdU) incorporation in vivo. Fig. 5 E shows sections of cal-
varia from 4-d-old wild-type and Lrp5
 /  mice. Significantly
fewer labeled nuclei were detected in sections from Lrp5
 / 
mice compared to those derived from wild-type mice (Fig. 5
E). The total number of osteoblasts was also decreased in
Lrp5
 /  calvaria but even after correction for this decreased
cell number there was still a significantly lower mitotic index
for mutant osteoblasts in vivo (Fig. 5 F). To assess whether
this proliferation defect extended to progenitors of the os-
teoblast lineage, we determined the number of stromal cell
progenitors (CFU-F) in wild-type and Lrp5
 /  bone mar-
row. The numbers of nucleated bone marrow cells obtained
from wild-type and Lrp5
 /  bone marrow were similar (un-
published data). However, as shown in Fig. 5 G, Lrp5
 / 
bone marrow cells formed almost twofold fewer alkaline
phosphatase–positive colonies than wild-type bone marrow
cells, suggesting the existence of an early proliferation defect
in the osteoblast lineage. There was no increased apoptosis
in the calvaria of Lrp5
 /  mice (Fig. 5 H), indicating that
the low mitotic index of mutant osteoblasts was solely due to
a proliferation defect.
To determine if the osteoblast phenotype affected the clas-
sical Cbfa1 pathway controlling osteoblast differentiation we
examined the expression of Cbfa1 in calvaria, long bones,
and primary osteoblasts. As shown in Fig. 5 I, Cbfa1 expres-
sion was not decreased in the absence of Lrp5, indicating
that this bone phenotype develops in a Cbfa1-independent
manner. Because there are fewer osteoblasts in Lrp5
 /  cal-
varia and long bones, it is possible that Cbfa1 may be upreg-
ulated in these mice. Moreover, the normal expression of
Osteocalcin in Lrp5
 /  (Fig. 5 J) mice suggests also that os-
teoblast differentiation is not affected in the absence of
Lrp5.
In summary, in vivo and cell-based assays support the hy-
pothesis that the low bone mass phenotype observed in
Lrp5
 /  mice is due to two main defects, both occurring in a
Cbfa1-independent manner: a decrease in osteoblast prolif-
eration evidenced by the BrdU in vivo labeling experiments,
and a decrease in bone matrix deposition shown by the de-
creased BFR.
Lrp5 acts as a Wnt receptor in osteoblasts
The homology between arrow, a coreceptor for wingless in
Drosophila, and Lrp5, as well as the requirement of Lrp5 for
Wnt signaling in NIH3T3 fibroblasts (Wehrli, 1999; Mao
et al., 2001), suggested that the bone phenotype of Lrp5
 / 
mice may be secondary to a defect in Wnt signaling in osteo-
blasts.
To test this hypothesis, we first performed DNA cotrans-
fection experiments in primary calvarial osteoblasts obtained
from wild-type or Lrp5
 /  4-d-old mice. Cells were trans-
fected with a luciferase reporter construct containing multi-
ple copies of an oligonucleotide containing the Lef1 binding
site (TOPtkluc) (Korinek et al., 1997), as well as a Lef1 ex-
pression vector. Using this assay, cotransfection of a Wnt1
expression vector consistently enhanced Lef1-dependent
transcription to a higher degree in wild-type than in Lrp5
 / 
primary osteoblasts (Fig. 6 A). Importantly, cotransfection
of an LRP5 expression vector into Lrp5
 /  osteoblasts re-
stored the ability of Wnt1 to induce Lef1-dependent gene
expression to wild-type levels (Fig. 6 B).
To identify a subgroup of Wnt proteins requiring LRP5
to better transduce its signal in osteoblasts, we also per-
formed DNA cotransfection experiments in primary osteo-
blasts using an expression vector for Wnt4 or a conditioned
medium from cells producing soluble Wnt3a (Shibamoto et
al., 1998). Soluble Wnt3a increased Lef1-dependent gene
expression equally in wild-type and Lrp5
 /  osteoblasts, in-
dicating that in this assay there is no detectable signaling de-
fect for Wnt3a in the absence of Lrp5. However, as the addi-
tion of an LRP5 expression vector further increased twofold
the ability of Wnt3a to stimulate Lef1-dependent gene ex-
pression in osteoblasts, we cannot rule out the possibility
that optimal Wnt3a signaling may require Lrp5 (Fig. 6 B).
In contrast, Wnt4 stimulated Lef1-dependent gene expres-
sion to a lesser extent, and this was virtually not affected by
the presence of LRP5 (Fig. 6 C). Western blot analyses were
performed to demonstrate the presence of each protein after
DNA transfection; these analyses also demonstrated the abil-
ity of LRP5 to enhance Wnt-dependent accumulation of cy-
tosolic  -catenin levels (Figs. 6 D and S2). Coimmunopre-
cipitation experiments demonstrated that Wnt1 and Wnt4
are able to bind directly to LRP5 (Fig. 6 E). These results in-Wnt regulation of bone formation | Kato et al. 309
dicate that, in the conditions of this assay and among the
Wnt proteins tested, Wnt1 or a related Wnt protein may be
a preferred ligand for LRP5 in osteoblasts.
Expression of Wnts, and of genes encoding Wnt 
signaling molecules in bone
Lrp5 is expressed in osteoblasts at early and late stages of differ-
entiation (Fig. 1 B). To determine if the low bone mass pheno-
type in the Lrp5
 /  mice was consistent with the expression
pattern of other molecules involved in Wnt signaling, we ana-
lyzed their expression in bone and in osteoblasts. Wnt1 was ex-
pressed at high levels in calvaria in both wild-type and Lrp5
 / 
mice (Fig. 7 A). Wnt1 expression was detected in primary os-
teoblasts at higher amplification levels, but was absent from
day 0 Lrp5
 /  osteoblasts (Fig. 7 A), suggesting that Wnt1 ex-
pression by proliferating osteoblasts requires the presence of
Lrp5. The normal level of Wnt1 expression in day 10 Lrp5
 / 
osteoblasts suggests that Lrp5 is not necessary for Wnt1 expres-
sion at later stages of differentiation when proliferation ceases.
Wnt4 and 14 were also expressed in calvaria and in osteoblasts
in wild-type and Lrp5
 /  samples (Fig. 7 B). Wnt3a expression
was not detected in calvaria, long bones, or primary osteoblasts,
regardless of the level of amplification indicating that it may
not be the ligand for Lrp5 in bone (unpublished data).
The Wnt receptors Frizzled2 and 6 were both expressed in
calvaria and primary osteoblasts and their expression levels
were unaffected by the lack of Lrp5 (Fig. 7 B). Because Lef1
and Tcf4 had previously been shown to be expressed in bone
by in situ hybridization (Hartmann and Tabin, 2000), we
studied the expression of these two members of the Lef/Tcf
family of transcription factors. Both were expressed in pri-
mary osteoblasts. Interestingly Lef1, but not Tcf4, expression
was markedly decreased in Lrp5
 /  osteoblasts (Fig. 7 C). In
summary, members of the canonical Wnt signaling pathway
are present in osteoblasts and their expression is affected by
Lrp5 disruption.
Figure 6. LRP5-dependent activation of gene 
expression by Wnt proteins. (A) Wnt1 activates 
Lef1-dependent gene expression in wild-type but 
poorly in Lrp5
 /  primary osteoblasts. (B) Cotrans-
fection of LRP5 in Lrp5
 /  osteoblasts allows Wnt1 
to activate Lef1-dependent gene expression to 
wild-type levels. (C) Cotransfection of LRP5 with 
Wnt3a-conditioned medium or an expression vec-
tor for Wnt4 in wild-type (white bars) and Lrp5
 /  
primary osteoblasts (black bars). (D) Western blot 
analysis to confirm expression of transfected plas-
mids and to demonstrate the ability of Wnt1-LRP5 
cotransfection to stimulate cytoplasmic  -catenin 
accumulation. (E) Direct binding of LRP5 to Wnt1 
or Wnt4. COS-7 cells were transfected with Flag-
LRP5 and HA-Wnt1 or HA-Wnt4 as indicated. 
LRP5 or Wnts were immunoprecipitated from 
the cell lysate using anti-Flag or anti-HA antibody, 
subjected to SDS-PAGE and immunoblotted with 
anti-HA and anti-Flag antibody, respectively.310 The Journal of Cell Biology | Volume 157, Number 2, 2002
Abnormal macrophage-mediated apoptosis 
in the eyes of Lrp5
 /  mice
Postnatal development of the rodent eye involves the regres-
sion of three related vascular networks called the pupillary
membrane (PM), tunica vasculosa lentis (TVL), and the hya-
loid vessels (Fig. 8 A). In wild-type mice, regression of these
networks is normally complete by P12 for the PM and by P16
for the TVL and hyaloid vessels (Ito and Yoshioka, 1999).
Histological analysis of eyes at 6 mo of age revealed the pres-
ence of hyaloid vessels in 70% (28/40) of Lrp5
 /  mice and in
none of the wild-type controls. To define the onset of this
phenotype, we performed a series of dissections of the capil-
lary networks in order to compare their rates of regression. Al-
though both the PM and TVL showed mild delays in regres-
sion (unpublished data), this response was dramatic in the
hyaloid vessels; quantification of the number of capillary seg-
ments over a P3–P8 time course (Fig. 8 B) indicated that loss
of segments was much slower in Lrp5
 /  mice. The presence
of equal numbers of capillary segments in wild-type and
Lrp5
 /  mice at P3 indicated that the persistence was not a
trivial consequence of early vessel overgrowth in Lrp5
 / 
mice. The persistence of the hyaloid vessels is readily visual-
ized when comparing histological preparations from wild-type
(Fig. 8, D–F) and Lrp5
 /  mice (Fig. 8, G–I) over the P3–P8
time course. Higher magnifications of hyaloid vessel prepara-
tions (Fig. 2, G–L) indicate that the number of macrophages
associated with wild-type and Lrp5
 /  hyaloid vessels is not
different. No delay in hyaloid vessel regression was detected in
Lrp
    mice (unpublished data).
To examine the cellular basis for the lack of capillary regres-
sion in Lrp5
 /  mice, we performed TUNEL analysis (Gavrieli
et al., 1992) to detect apoptotic cells. Regression of the PM is
known to occur on a segmental basis (Lang et al., 1994), and
hyaloid vessel preparations from both wild-type and Lrp5
 / 
mice showed segmental TUNEL labeling consistent with this
expectation (Fig. 8, D–F, wild-type, and G–I, Lrp5
 / ). How-
ever, quantification indicates that the proportion of TUNEL-
labeled segments is lower in Lrp5
 /  mice at all time points ex-
amined (Fig. 8 C). Furthermore, in the wild-type, the propor-
tion of apoptotic segments increases from P3 to P5 and P8 in-
dicating ongoing regression, whereas in Lrp5
 /  mice there is
no significant change. Based on our understanding that regres-
sion of the ocular vessel networks is dependent on induced pro-
grammed cell death (Lang and Bishop, 1993; Diez-Roux and
Lang, 1997), these data suggest that a reduced level of apopto-
sis is the cause of the persistence of the hyaloid vessels.
Discussion
Lrp5-deficient mice display two phenotypes: a low bone
mass due to decreased bone formation and a persistent em-
bryonic eye vascularization due to failed macrophage-medi-
ated apoptosis. Several lines of evidence indicate that we
have characterized the phenotypic consequences of a loss-of-
function allele. First, there was no Lrp5 expression detected
by a 3  probe in Lrp5
 /  mice, indicating that no exon skip-
ping has occurred. Second, although the allele is dominant
for the bone mass abnormality, the phenotype in homozy-
gotes is more severe than in heterozygotes. Third, the eye
phenotype is recessive. Fourth, and most compelling, the
phenotypes of Lrp5
 /  mice are virtually identical to those
observed in patients with a similar mutation as well as those
lacking the entire LRP5 protein (Gong et al., 2001).
Lrp5 as a determinant of peak bone mass in vertebrates
Three aspects of osteoblast biology could be controlled by
the Lrp5 signaling pathway: differentiation, proliferation,
and function. The decreased number of bone marrow stro-
mal cell progenitors may be viewed as a differentiation de-
fect. However, the normal expression of Cbfa1, the earliest
marker of osteoblast differentiation, and of Osteocalcin, the
latest marker of osteoblast differentiation, together with
the absence of any detectable phenotypic abnormalities in
Lrp5
 /  mice before birth, strongly suggest that the Lrp5
Figure 7. Expression of Wnts and Wnt 
signaling molecules in bone. (A) Wnt1 is 
highly expressed in calvaria compared 
with day 11 (E11) embryos or primary 
osteoblasts (24 cycle RT-PCR, top). 
Wnt1 expression is not present in prolif-
erating (D0) Lrp5
 /  osteoblasts (30 cycle 
RT-PCR, middle). (B) Wnt4, Wnt14, 
Frizzled2, and Frizzled6 expression in 
calvaria and primary osteoblasts (24 
cycle RT-PCR). (C) Decreased expres-
sion of Lef1, but not Tcf4, in Lrp5
 /  
osteoblasts determined by RNase
protection assay.Wnt regulation of bone formation | Kato et al. 311
signaling pathway does not play a major role in the pro-
cess of Cbfa1-dependent osteoblast differentiation. Several
lines of evidence suggest that the Lrp5 signaling pathway
plays an important role in osteoblast proliferation. First,
the total number of osteoblasts was decreased in the skele-
ton of Lrp5
 /   mice compared with wild-type controls.
Second, and more importantly, by in vivo BrdU labeling
we observed a lower proportion of proliferating osteoblasts
in  Lrp5
 /   mice than in wild-type controls. Third, the
number of stromal cell progenitors was markedly reduced
in the bone marrow of Lrp5
 /  mice. These developmental
defects are not the only ones observed in osteoblasts in the
absence of Lrp5. Indeed, the reduction in the MAR in
Lrp5
 /  mice and the delay in mineralization observed in
primary cultures of Lrp5
 /  osteoblasts suggest that the
function of differentiated osteoblasts, i.e., bone matrix
deposition, is decreased in Lrp5
 /  mice.
Together, these two abnormalities lead to the inability of
Lrp5
 /  mice to reach a normal bone mass early during life.
The bone mass normally achieved early on in vertebrate life,
also called peak bone mass, has been shown to be genetically
controlled (Johnston and Slemenda, 1993). Our data are
consistent with the hypothesis that the Lrp5 signal transduc-
tion pathway is one of the genetic determinants of peak
bone mass in vertebrates.
Uncovering a Cbfa1-independent control 
of osteoblast biology
Our findings, together with those of Gong et al. (2001) and
Little et al. (2002), have two implications. First, the observa-
Figure 8. Regression of hyaloid vessels 
is defective in Lrp5
 /  mice. (A) 
Schematic indicating the location of the 
temporary ocular capillary networks 
including the hyaloid vessels (vasa 
hyaloidia propria), the TVL and PM. (B) 
Quantification of the number of hyaloid 
vessels during a developmental time-
course for wild-type (red line) and Lrp5
 /  
mice (green line). (C) Quantification of 
the apoptotic index (apoptotic capillary 
segments per total capillary segments) 
within the hyaloid vessels during a 
developmental time course for wild-type 
(red line) and Lrp5
 /  mice (green line). 
Whole-mount preparations of hyaloid 
vessels for wild-type (D–F) and Lrp5
 /  
mice (G–I). Hyaloid vessel preparations 
are shown as pairs of brightfield and 
fluorescence images. Brightfield images 
are shown in the upper panel of each 
pair. In the lower panel, DAPI labeling 
of nuclei is shown in blue and apoptotic 
cell detection in red. The normal process 
of regression in wild-type hyaloid vessels 
is apparent (D to F) as is the lack of 
regression and a lower number of 
apoptotic capillary segments in Lrp5
 /  
hyaloid vessels (G to I). D–I are at 50  
magnification.312 The Journal of Cell Biology | Volume 157, Number 2, 2002
tion that Lrp5 signaling is important for osteoblast prolifera-
tion and bone formation suggests an additional, postnatal
function for the Wnt proteins in skeletal biology. However,
we are aware that despite the interaction between Wnt1 and
Lrp5 reported here, the Wnt proteins may not be the only
class of secreted molecules transducing their signals through
Lrp5. This is an important concern, as other Lrps have been
shown to have multiple ligands (Herz and Strickland, 2001).
Second, Lrp5 disruption reveals the existence of an addi-
tional, evolutionarily conserved, pathway besides Cbfa1-depen-
dent gene expression, for controlling osteoblast proliferation
and bone formation. The normal expression of Cbfa1 in
Lrp5
 /  mice implicates other transcriptional mediators in
this alternate pathway. Because Lef/Tcf proteins are well
characterized transcriptional mediators of Wnt actions in
other organ systems (Merrill et al., 2001) and are expressed
in osteoblasts, one or more members of this family are likely
to control some aspects of osteoblast biology. An important
question in bone biology will now be to define which aspects
of bone biology are affected by Wnt and Lef/Tcf proteins
and how these functions relate to Lrp5 function.
Wnt proteins and postnatal bone formation
Cell culture analyses have shown that LRP5 acts as a core-
ceptor for Wnt proteins (Mao et al., 2001). Our analysis de-
fines this interaction as being one of direct binding and
demonstrates its biological importance in vivo. We also ob-
served expression of Wnt, Frizzled,  -catenin, and Tcf genes
in osteoblasts. The decreased expression of Lef1 in Lrp5
 / 
osteoblasts suggests that Lef1 expression is controlled di-
rectly or indirectly by the Lrp5 signaling pathway, and that
Lef1 may be the preferred transcriptional effector of the var-
ious functions of this pathway in osteoblasts.
What may be the Wnt protein(s) that control osteoblast
proliferation and function? The absence of Wnt3a expres-
sion in any bone sample analyzed implies that it is not the
ligand of Lrp5 in bone. The accelerated ossification caused
by Wnt4 overexpression in chick limb buds (Hartmann and
Tabin, 2000) is the mirror image of the bone phenotype of
Lrp5
 /  mice. To our surprise, DNA cotransfection experi-
ments showed that Wnt1, but not Wnt4, induces Lef1-depen-
dent gene expression. Wnt proteins have been separated
into two categories based on their ability to induce dorsal
axis duplication in Xenopus embryos. Members of the Xwnt8
family induce axis duplication, whereas members of the
Xwnt5a do not. In that respect, it is interesting to note that
Wnt1 belongs to the first family, whereas Wnt4 belongs to
the second family (Wodarz and Nusse, 1998). The function
of Wnt1 itself during skeletal development and during bone
formation has not been reported, in part because Wnt1-defi-
cient mice die shortly after birth (McMahon and Bradley,
1990). This question can now be addressed by a conditional
gene inactivation strategy. The identification of the ligand(s)
for Lrp5 is an urgent need in the field of bone biology.
Lrp5 requirement during eye development
The mammalian eye is vascularized during embryonic devel-
opment with three connected but anatomically distinct net-
works: the PM, TVL, and hyaloid vessels (Fig. 8 A). In the
mouse, all three networks regress postnatally due to apopto-
sis of capillary cells (Lang et al., 1994; Meeson et al., 1996;
Lang, 1997; Ito and Yoshioka, 1999). Lrp5
 /  mice have a
reduced level of capillary cell apoptosis and a defect in hya-
loid vessel regression resulting in the retention of the hyaloid
vasculature throughout life. It has been shown previously
that ocular macrophages found closely associated with these
vascular networks are necessary and sufficient for the cell
death that drives the regression process (Lang and Bishop,
1993; Diez-Roux and Lang, 1997; Lang, 1997). Lrp5 is pro-
duced by macrophages but is not detectable in endothelial
cells, suggesting that Lrp5 has a crucial role to play in mac-
rophage-induced capillary cell death.
The presence of normal numbers of ocular macrophages
in Lrp5
 /  mice indicates that Lrp5 is not critical for macro-
phage survival or migration. This raises the hypothesis that
an Lrp5 ligand, perhaps a member of the Wnt family, is crit-
ical for macrophage function, and more specifically, for the
killing action of macrophages. Although a precise under-
standing of the role of Lrp5 in programmed capillary regres-
sion will require further experimentation, this phenotype is
of great interest because it indicates for the first time a sig-
naling pathway that is required for macrophages to kill other
cells in a developmental context. Even more intriguing is the
possibility that this mouse model will lead us to an under-
standing of the means by which macrophage-mediated en-
dothelial cell killing might be harnessed for therapeutic
benefit in the treatment of diseases characterized by inappro-
priate angiogenesis.
Materials and methods
Lrp5 targeting and generation of Lrp5
 /  mice
To generate a targeting vector, genomic clones containing exons 6–8 of
Lrp5 were isolated from a mouse 129/Sv genomic library. A replacement
vector was constructed as follows: A PGK-neo cassette and IRES- -galac-
tosidase gene was inserted into an SphI site in exon 6 (Fig. S1 A). The lin-
earized vector was electroporated into embryonic stem (ES) (R1) cells, and
after double selection by G418 and FIAU, Lrp5-targeted ES cell clones
were identified by Southern blot hybridization using 5  and 3  flanking
probes (Fig. S1 B). The ES cells carrying the correct mutation were injected
into C57BL/6J blastocysts. Resulting male chimeras were mated to C57BL/
6J females, and heterozygous offspring were identified by Southern blot
hybridization. Northern blots were performed with 5  g poly-A  RNA
(Fig. 1 B) or 1–10  g total RNA (Figs. 1 C and 5 I) according to standard
procedures. A 401-bp fragment from a PstI and BamHI digestion of the
Lrp5 cDNA was used as a 5  probe, located between nucleotide positions
71 (exon 1) and 471 (exon 2) of the Lrp5 open reading frame. A 520-bp
fragment from a BamHI and PstI digestion of the Lrp5 cDNA was used as a
3  probe, located between nucleotide positions 2301 (exon 10) and 2821
(exon 12) of the Lrp5 open reading frame.
Immunohistochemistry
Frozen sections were cut at 10  m, and Lrp5 was detected with the AS884
murine-specific N-terminal antibody as previously described (Figueroa et
al., 2000). Primary antibody was detected with an Alexa Fluor-594
chicken anti–rabbit secondary antibody (Molecular Probes). Anti-Cbfa1
antibody #770 was used to detect osteoblasts on alternate sections and de-
tected with an anti–rabbit HRP secondary antibody (Santa Cruz Biotech-
nology), followed by detection with DAB (Vector Laboratories). Macro-
phages were identified using an F4/80 antibody (Serotec) followed by
detection with an Alexa Fluor-647 chicken anti–rat secondary antibody
(Molecular Probes). Sections were counterstained with Hoechst stain to vi-
sualize nuclei.
Morphological and histological analyses
Skeletons from pups were prepared as described (Kochhar, 1973) and
stained with Alcian blue and Alizarin red. All mice were injected with cal-
cein, 10 and 2 d prior to sacrifice (Vignery and Baron, 1980). Undecalci-Wnt regulation of bone formation | Kato et al. 313
fied bones were fixed, dehydrated through an ethanol series, embedded in
methylmethacrylate at 4 C, and 7- m sections were prepared. Sections
were stained with von Kossa reagent and counterstained by van Gieson re-
agent. Histomorphometric analysis was performed according to standard
protocols (Parfitt et al., 1987) using the OsteoMeasure Analysis System
(Osteometrics). Two sections from the third lumbar vertebra (L3) and two
sections from L4 were measured for bone volume and tissue volume. All
sections were  25  m, i.e., more than one trabecular width apart. The
mean distance between the calcein double labels was measured from 12-
 m sections and used to calculate the MAR. These sections were also used
to determine the mineralizing surface. Bone formation rate was calculated
as the product of mineralizing surface per bone surface (Parfitt et al.,
1987). Osteoblasts were counted separately in the primary and secondary
spongiosa according to morphological criteria; cuboidal cells attached to
bone occurring in clusters and having a large, asymmetrically positioned
nucleus. The primary spongiosa was defined as the metaphyseal bone
within one high power field (40  objective) of the growth plate. Statistical
differences between groups were assessed by Student’s t test.
Proliferation studies
Stromal cell progenitors were obtained by flushing bone marrow from 1–3-
mo-old wild-type and Lrp5
 /  mouse femora and tibiae. 0.5, 1.0, 2.0, and
4.0   10
7 nucleated cells were plated in 75-cm
2 flasks in  MEM/15% FBS,
which was supplemented with 50  g/ml ascorbic acid and fresh medium
after 3 d of culture. The medium was then changed every 2 d with fresh
ascorbic acid added until harvest at day 10–14. Colonies were stained for
alkaline phosphatase activity as previously described (Ducy et al., 1999),
and the experiment repeated three times (n   5–8 mice per genotype per
experiment). For in vivo BrdU labeling, 4-d-old mice were injected intra-
peritoneally with 100  l of 100  M BrdU in PBS, sacrificed 4 h later, cal-
varia were isolated, fixed for 6 h in 10% formalin in PBS and processed in
paraffin. Sections of 5  m were prepared and stained with the BrdU stain-
ing kit (Zymed). Apoptotic cells were detected in calvarial sections by mea-
suring terminal transferase labeling of cells (DeadEnd; Promega). Eight ani-
mals per genotype were used and three sections per animal were studied.
Statistical differences between groups were assessed by Student’s t test.
Cell culture, DNA transfection, Western blotting,
and immunoprecipitation
Primary osteoblast cultures from calvaria of newborn, wild-type, and
Lrp5
 /  mice were established and mineralized in vitro as previously de-
scribed (Ducy et al., 1999). Transfections were performed in 24-well plates
(20,000 cells/well; Fugene6; Roche) in triplicate and repeated at least three
times; cells were harvested 40 h after transfection. Empty vector was added
to keep the total amount of DNA constant at 225 ng/well. The FOPtkluc re-
porter, containing mutated Lef1 binding sites, was used in control transfec-
tions. All luciferase values were corrected for  -galactosidase activity as a
control for transfection efficiency. For Western blot analysis, primary os-
teoblast lysates were collected in physiological buffer with protease inhibi-
tor cocktail (Roche), homogenized, fractionated into cytosolic and mem-
brane fractions by ultracentrifugation at 100,000 g for 90 min, and
separated by SDS-PAGE. The epitope tags were detected by the anti-FLAG
M2 antibody (Sigma-Aldrich) and anti-HA antibody (Santa Cruz Biotech-
nology). The anti– -catenin antibody was obtained from Transduction
Laboratories. Coimmunoprecipiation assay was performed using trans-
fected COS-7 cells that were lysed with 400  l of RIPA buffer (50 mM Tris/
Cl, pH 8, 150 mM NaCl, 1% NP-40, 0.5% Na deoxycholate, 0.1% SDS)
with protease inhibitor cocktail. After removing cell debris by brief centrif-
ugation, 200  l of cell lysate were incubated with 10  g of anti-HA or
anti-Flag antibody for 90 min. 25  l of protein G Sepharose (Amersham
Pharmacia Biotech) was added and incubated for 90 min. The Sepharose
was washed three times, and precipitated proteins were separated by SDS-
PAGE followed by Western blot analysis using the anti-Flag or anti-HA an-
tibodies.
Gene expression analyses
Total RNA was isolated from calvaria, long bones stripped of bone marrow
and primary osteoblasts from P4 wild-type and mutant mice using Trizol
(Invitrogen), and treated with DNaseI (Invitrogen). Reverse transcription
was performed on 4  g of RNA using SuperscriptII (Invitrogen) according
to the manufacturer’s protocol. Reverse transcription reactions were ampli-
fied by PCR using gene-specific primers in standard reaction conditions
with a 2-min initial denaturation step followed by 24 or 30 cycles of 94 C–
20 s, 58 C–20 s, and 72 C–60 s. Reverse transcribed cDNA from day 11
embryos (E11) was used as a positive control for all PCR reactions. All
products were resolved on a 1.6% agarose gel and analyzed by Southern
blot hybridization using specific probes. PCR primers used for amplifica-
tion are available upon request. RNase protection assays were performed
on 5  g total RNA (pretreated with DNaseI) using gel eluted probes pre-
pared with the MAXIscript kit (Ambion). The RPAIII kit (Ambion) was used,
products were separated on a 7.5% acrylamide gel and detected by auto-
radiography. The sizes of the full-length probes and protected fragments
were confirmed using the RNA Century ladder (Ambion). The Lef1 and
Tcf4 templates were those used for in situ hybridization analysis in Hart-
mann and Tabin (2000).
Preparation of hyaloid vessels, TUNEL labeling,
and quantification
Animals were anesthetized, perfused with 4% PFA in PBS, eyeballs enu-
cleated, and injected with a 1.5% solution of low melting point agarose in
PBS. After 30 min at room temperature, eyeballs were incised around the
equator. The hyaloid vessels embedded in agarose were removed from the
retinal cup, heated on a glass slide, washed with PBS, and air dried; hya-
loid vessel preparations were permeabilized with 0.05% Triton X-100 in
PBS and processed for TUNEL labeling. Apoptotic cells were labeled using
the DeadEnd kit (Promega) and visualized with streptavidin-Alexa Fluor
568 conjugate (Molecular Probes). Images were taken using Zeiss Ax-
ioplan microscope and a Sony DKC5000 digital camera. The total number
of blood vessels and the number of TUNEL-labeled segments were quanti-
fied using established methods (Ito and Yoshioka, 1999) where we
counted the number of vessels crossing a circle drawn at 50% of the maxi-
mum radial spread of the preparations. The apoptotic index was calculated
as the ratio of the number of TUNEL-labeled vessels to the total number of
blood vessels. At least three hyaloid vessel preparations were quantified
for each time-point. Error bars represent standard errors.
Chemistry and hormone measurements
Calcium and phosphate were measured by their respective kits (Sigma-
Aldrich). Deoxypyridinoline crosslinks were measured in morning urines
using the Pyrilinks-D immunoassay kit (Metra Biosystems). Creatinine val-
ues were used for standardization between urine samples (Creatinine kit;
Metra Biosystems) (n   8 animals per genotype).
Online supplemental material
Online supplemental materials are available at http://www/jcb.org/cgi/
content/full/200201089/DC1.  Fig. S1 depicts the targeting strategy used
for Lrp5, the Southern blot confirming correct targeting and genotyping
data showing a normal Mendelian distribution at birth but slightly fewer
animals (22.1%) alive at 1 mo of age.  Fig. S2 shows a radiograph of a tib-
ial fracture that occurred in a 2-mo-old Lrp5
2/2 mouse. Fig. S3 shows West-
ern blots for the Wnt3a and Wnt4 transfection experiments to confirm ex-
pression and show cytoplasmic accumulation of  -catenin.
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